Sanofi
Novel Selection Marker for Cell Transfection and Protein Production

Last updated:

Abstract:

The present invention is within the field of industrial protein production. The invention provides a novel expression system using dehydroorotate dehydrogenase (DHODH) as a selection marker in combination with leflunomide or a metabolite thereof, notably for use in mammalian cell lines. Expression vectors encoding DHODH, cell lines comprising said vectors and methods of producing recombinant proteins are also provided.

Status:
Application
Type:

Utility

Filling date:

26 Dec 2019

Issue date:

25 Jun 2020